Specialized AI platform for cancer research built on Wheelder's Deep Research methodology. Integrates 30+ biomedical APIs for evidence-based answers grounded in real research.
Wheelder — Progressive Development Platform
Published: March 11, 2026 · Version 1.0
Specialized AI platform for cancer research built on Wheelder's Deep Research methodology. Integrates 30+ biomedical APIs for evidence-based answers grounded in real research.
Built on Wheelder's founding Deep Research methodology
"Accelerating Research and Development to the ultimate level possible, to save more lives"
Wheelder is the founding and leading Deep Research platform. We invented Deep Research methodology to enable researchers to ask complex questions and receive evidence-based answers grounded in real data — not hallucinations.
Wheelder Cancer Research is our specialized application of this methodology to cancer research. We are not a full-stack healthcare platform. Instead, we focus exclusively on cancer research while remaining committed to contributing our innovations to the broader research community.
Our vision: Work together with all existing efforts — Google's cancer research initiatives, OpenAI's health tools, academic institutions, and clinical researchers — to unify our contributions under one ceiling and make a meaningful difference in accelerating cancer research and saving lives.
January 2026: Wheelder began conceptualizing Deep Research methodology and cancer research applications.
Sunday, March 9, 2026: Development of Wheelder Cancer Research began — independent work focused on cancer-specific AI research.
March 10, 2026 (Today): Release of Wheelder Cancer Research v1.0. Note: Google announced cancer research support and OpenAI added health sidebar today. Wheelder's work is independent and complementary — we welcome collaboration with all players in this space.
Promise Made, Promise Kept: This is just the beginning. We are committed to continuous improvement and deeper integration of cancer research data and methodologies.
Wheelder Cancer Research is a specialized AI platform built exclusively for cancer research and clinical inquiry. Unlike general-purpose AI assistants (ChatGPT, Claude, Gemini), this platform is deeply trained on cancer-specific biomedical data sources and implements Wheelder's proprietary Deep Research methodology.
The platform integrates 30+ peer-reviewed biomedical APIs and databases — from PubMed's 35M+ literature abstracts to ClinicalTrials.gov's 400K+ active trials, UniProt's protein data, Reactome's pathway information, and specialized cancer genomics databases like cBioPortal and GDC/TCGA.
When a researcher asks a question, Wheelder Cancer Research:
This ensures researchers get answers backed by actual research, not AI hallucinations.
Cancer research is one of the most critical and complex domains in biomedicine. General-purpose AI assistants lack the specialized training, real-time data access, and research methodology needed for cancer research. Wheelder Cancer Research addresses five critical gaps:
| Gap | Problem | Wheelder Solution |
|---|---|---|
| Domain Training | General AI lacks cancer-specific knowledge | 30+ cancer-focused APIs + specialized query classification |
| Real-Time Data | AI training data becomes stale | Live API integration with 24-hour caching |
| Citation Grounding | AI hallucinations without source verification | API-Augmented Generation with primary source citations |
| Molecular Understanding | Limited protein/pathway/genomics knowledge | UniProt, Reactome, AlphaFold, STRING, cBioPortal integration |
| Research Workflow | No structured methodology for hypothesis testing | Deep Research workflows + tool recommendations |
Wheelder invented the Deep Research methodology — a systematic approach to multi-stage research inquiry that goes beyond single-turn Q&A. Deep Research enables researchers to:
In Wheelder Cancer Research, the "Deep Research" button triggers a workflow that:
Genomics & Protein Data (8 sources)
Clinical & Research Data (6 sources)
Drug & Medication Data (5 sources)
Disease & Health Data (11 sources)
| Feature | Description | Status |
|---|---|---|
| Real-Time Biomedical Data | Live integration with 30+ APIs | ✅ Live |
| API-Augmented Generation | Answers grounded in real data + citations | ✅ Live |
| Deep Research Workflows | Multi-stage research methodology | ✅ Live |
| Tool Recommendations | Claude, ChatGPT, Gemini, Grok, Copilot, Meta AI, Kimi2 | ✅ Live |
| Image Generation | Visual summaries of research findings | ✅ Live |
| Session Threading | Conversation history with context preservation | ✅ Live |
| 24-Hour API Caching | Reduces API calls, improves response time | ✅ Live |
| CSRF Protection | Secure AJAX endpoints | ✅ Live |
| Rate Limiting | Prevents abuse and API quota exhaustion | ✅ Live |
User Query (Cancer Research Question)
↓
Query Classifier (analyzes intent, identifies research type)
↓
DataSourceManager (selects 1-3 relevant biomedical APIs)
↓
Parallel API Fetches (cached 24h in SQLite)
├─ PubMed, ClinicalTrials, UniProt, Reactome, etc.
└─ Non-fatal: if API fails, Groq still answers
↓
Augmented Prompt (original query + real API data)
↓
Groq LLaMA 3.3 70B (generates evidence-based answer)
↓
Answer Summarization (1-2 sentence summary)
↓
Image Generation (Pollinations AI from summary)
↓
Deep Research Workflow (optional multi-stage refinement)
├─ Generate workflow steps
├─ Recommend specialized AI tools
└─ Open modal with tool links
↓
User sees: Answer + Sources + Recommended Tools + Generated Image
| Component | Technology | Why |
|---|---|---|
| Backend | PHP 8+ | Fast, reliable, widely deployed |
| Database | SQLite | Lightweight, serverless, 24h API cache |
| AI Engine | Groq LLaMA 3.3 70B | Fast inference, free tier, strong reasoning |
| Image Generation | Pollinations AI | Free, no API key, instant generation |
| Frontend | Bootstrap 5, Vanilla JS | Responsive, fast, no build step |
| Server | Nginx, PHP-FPM | High performance, low resource usage |
| Biomedical APIs | 30+ peer-reviewed sources | Real data, no hallucinations, citations |
API-Augmented Generation is Wheelder's proprietary methodology that combines real biomedical data with AI generation. Instead of relying solely on training data (which becomes stale), AAG:
This approach eliminates hallucinations and ensures answers are always backed by evidence.
Wheelder Cancer Research is built on peer-reviewed research in AI, information retrieval, and cancer biology:
| Feature | Wheelder Cancer | ChatGPT | Google Health | OpenAI Health |
|---|---|---|---|---|
| Cancer-Specific | ✅ Yes | ⚠️ General | ⚠️ General | ⚠️ General |
| Real-Time Biomedical APIs | ✅ 30+ sources | ❌ No | ⚠️ Limited | ⚠️ Limited |
| Citation Grounding | ✅ Primary sources | ⚠️ Partial | ✅ Yes | ✅ Yes |
| Deep Research Workflows | ✅ Yes | ❌ No | ❌ No | ❌ No |
| Tool Recommendations | ✅ 7+ tools | ❌ No | ❌ No | ❌ No |
| Open Source | ✅ Yes | ❌ No | ❌ No | ❌ No |
| Collaborative Vision | ✅ Works with all | ❌ Proprietary | ❌ Proprietary | ❌ Proprietary |
Wheelder Cancer Research is open source and publicly available. We believe cancer research should be a collaborative effort. We welcome contributions, feedback, and partnerships with academic institutions, clinical researchers, and other organizations working on cancer research.
Our vision is to work together with Google's cancer research initiatives, OpenAI's health tools, academic institutions, and clinical researchers to unify our contributions under one ceiling and make a meaningful difference in accelerating cancer research and saving lives.
Wheelder Cancer Research is the beginning of a larger mission. We are committed to continuous improvement, deeper integration of cancer research data, and collaborative partnerships with all organizations working to accelerate cancer research and save lives.
"Accelerating Research and Development to the ultimate level possible, to save more lives"
Built by Wheelder — The founding and leading Deep Research platform
March 10, 2026
Fakhri, A. B. (2026). Wheelder Cancer Research. Wheelder Innovation Documentation Series, v1.0. Retrieved from https://wheelder.com/releases/paper?id=9